TIM
ALT icon

Timelo Investment Management’s Altimmune ALT Stock Holding History

Timelo Investment Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-294,095
Closed -$2.99M – 27
2024
Q1 		$2.99M Sell
294,095
-515,000
-64% -$5.24M 1.14% 13
2023
Q4 		$9.1M Buy
809,095
+779,095
+2,597% +$3.25M 7.95% 3
2023
Q3 		$78K Buy
+30,000
New +$86.1K 0.1% 19
2022
Q3 		– Sell
-187,529
Closed -$2.19M – 58
2022
Q2 		$2.19M Buy
+187,529
New +$1.16M 2% 13

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Timelo Investment Management's ALT Position: Q2 2024 in Review

Timelo Investment Management sold out of Altimmune (ALT) in Q2 2024, closing a stake of 294,095 shares — an estimated $2.99M sold.

Timelo Investment Management first reported a position in ALT in Q2 2022 and held it in 4 quarters. The position peaked at $9.1M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • Timelo Investment Management reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • Timelo Investment Management sold 294,095 Altimmune shares in Q2 2024, an estimated $2.99M.
  • Timelo Investment Management first reported a position in Altimmune in Q2 2022 and held it in 4 quarters.
  • Timelo Investment Management's Altimmune position peaked at $9.1M in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Timelo Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.